ING1 Antibody (aa285-296)
Goat Polyclonal Antibody
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Application
| WB, IHC-P, IF, E |
---|---|
Primary Accession | Q9UK53 |
Reactivity | Human |
Host | Goat |
Clonality | Polyclonal |
Calculated MW | 47kDa |
Dilution | ELISA (1:4000-1:14000), IHC-P (2.5 µg/ml), WB (1:500-1:3000) |
Gene ID | 3621 |
---|---|
Other Names | Inhibitor of growth protein 1, ING1 |
Target/Specificity | Aa 285-296 of Human p33 ING1 protein (Inhibitor of growth family, member 1). This sequence shows 100% homology to all splice variants for ING1. |
Reconstitution & Storage | +4°C or -20°C, Avoid repeated freezing and thawing. |
Precautions | ING1 Antibody (aa285-296) is for research use only and not for use in diagnostic or therapeutic procedures. |
Name | ING1 |
---|---|
Function | Cooperates with p53/TP53 in the negative regulatory pathway of cell growth by modulating p53-dependent transcriptional activation. Implicated as a tumor suppressor gene. |
Cellular Location | Nucleus. |
Tissue Location | Isoform 2 was expressed in all normal tissues and cells examined, as well as in all breast cancer and melanoma cell lines examined. Isoform 3 was expressed in testis, liver, and kidney, weakly expressed in colon and brain and not expressed in breast and cultured melanocytes. Isoform 4 was highly expressed in testis and weakly expressed in brain, but not expressed in breast, colon, kidney, melanocytes, breast cancer or melanoma cell lines |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Cooperates with p53/TP53 in the negative regulatory pathway of cell growth by modulating p53-dependent transcriptional activation. Implicated as a tumor suppressor gene.
References
Garkavtsev I.A.,et al.Nat. Genet. 14:415-420(1996).
Garkavtsev I.A.,et al.Nat. Genet. 23:373-373(1999).
Jaeger D.,et al.Cancer Res. 59:6197-6204(1999).
Baranova A.V.,et al.Mol. Biol. (Mosk.) 34:263-269(2000).
Gunduz M.,et al.Cancer Res. 60:3143-3146(2000).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.